Canandaigua National Bank & Trust Co. Sells 1,295 Shares of The Procter & Gamble Company (NYSE:PG)

Canandaigua National Bank & Trust Co. decreased its holdings in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 1.6% during the 4th quarter, Holdings Channel reports. The firm owned 81,533 shares of the company’s stock after selling 1,295 shares during the quarter. Procter & Gamble comprises 1.3% of Canandaigua National Bank & Trust Co.’s holdings, making the stock its 13th largest position. Canandaigua National Bank & Trust Co.’s holdings in Procter & Gamble were worth $13,669,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the business. Concurrent Investment Advisors LLC increased its position in shares of Procter & Gamble by 4.5% during the third quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock worth $16,300,000 after acquiring an additional 4,035 shares in the last quarter. Copley Financial Group Inc. purchased a new stake in shares of Procter & Gamble in the third quarter worth approximately $668,000. Synovus Financial Corp boosted its position in shares of Procter & Gamble by 3.4% during the third quarter. Synovus Financial Corp now owns 185,134 shares of the company’s stock valued at $32,065,000 after buying an additional 6,077 shares during the last quarter. Radnor Capital Management LLC bought a new stake in Procter & Gamble during the third quarter worth $5,705,000. Finally, Welch Group LLC lifted its stake in Procter & Gamble by 0.9% during the 3rd quarter. Welch Group LLC now owns 323,870 shares of the company’s stock valued at $56,094,000 after acquiring an additional 2,990 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors.

Procter & Gamble Trading Down 2.7 %

Shares of PG traded down $4.52 during mid-day trading on Monday, reaching $160.61. The company’s stock had a trading volume of 8,538,484 shares, compared to its average volume of 5,385,503. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The Procter & Gamble Company has a 52 week low of $146.28 and a 52 week high of $180.43. The company’s fifty day moving average price is $170.21 and its two-hundred day moving average price is $169.85. The stock has a market cap of $378.24 billion, a PE ratio of 27.69, a P/E/G ratio of 3.70 and a beta of 0.45.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The firm had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. During the same period last year, the firm earned $1.83 earnings per share. The company’s revenue for the quarter was down .6% compared to the same quarter last year. On average, analysts predict that The Procter & Gamble Company will post 6.94 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were paid a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.51%. The ex-dividend date of this dividend was Friday, October 18th. Procter & Gamble’s dividend payout ratio (DPR) is presently 69.31%.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on the stock. Evercore ISI upped their target price on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research note on Monday, October 21st. Wells Fargo & Company raised their target price on Procter & Gamble from $188.00 to $190.00 and gave the stock an “overweight” rating in a research report on Friday, November 22nd. Piper Sandler started coverage on Procter & Gamble in a research report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 target price on the stock. DA Davidson reiterated a “buy” rating and issued a $209.00 price target on shares of Procter & Gamble in a research report on Friday, December 27th. Finally, Hsbc Global Res raised Procter & Gamble to a “strong-buy” rating in a report on Friday, October 4th. Eight analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, Procter & Gamble currently has an average rating of “Moderate Buy” and an average target price of $180.45.

View Our Latest Stock Analysis on PG

Insider Transactions at Procter & Gamble

In related news, insider Balaji Purushothaman sold 12,800 shares of the business’s stock in a transaction dated Thursday, October 24th. The stock was sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the transaction, the insider now owns 11,566 shares in the company, valued at $1,954,538.34. The trade was a 52.53 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Gary A. Coombe sold 47,847 shares of the business’s stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total value of $8,604,804.48. Following the transaction, the chief executive officer now directly owns 39,977 shares in the company, valued at $7,189,463.68. This trade represents a 54.48 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 75,439 shares of company stock worth $13,317,460. Insiders own 0.18% of the company’s stock.

About Procter & Gamble

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Recommended Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.